BRCA1--sowing the seeds crooked in the furrow

William D Foulkes1

  • 1William D. Foulkes is in the Program in Cancer Genetics, Department of Oncology, McGill University, Montreal, Quebec H2W 1S6, Canada. william.foulkes@mcgill.ca

Nature Genetics
|December 29, 2007
PubMed

Insights

Breast tumors lacking DNA repair show abnormal chromosome numbers. Microdeletions in PTEN are key lesions in these cancers, especially in BRCA1 mutation carriers.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • DNA double-strand break (DSB) repair is crucial for genomic stability.
  • Deficiencies in DSB repair pathways are linked to cancer development.
  • Aneuploidy, an abnormal chromosome number, is a common feature in cancer cells.

Discussion:

  • This study investigates the relationship between DSB repair deficiency, PTEN loss, and aneuploidy in breast tumors.
  • The research identifies microdeletions in the PTEN gene as a significant event leading to complete PTEN protein loss.
  • PTEN loss is implicated as a driver of aneuploidy in the context of impaired DSB repair.

Key Insights:

  • Breast tumors with compromised DNA double-strand break repair mechanisms exhibit aneuploidy.
  • Microdeletions leading to PTEN protein loss are identified as characteristic lesions in these tumors.
  • These PTEN-deficient tumors are particularly prevalent in patients with BRCA1 mutations.

Outlook:

  • Understanding the role of PTEN loss in DSB repair-deficient breast cancers can inform targeted therapeutic strategies.
  • Further research into the interplay between BRCA1, PTEN, and aneuploidy may reveal novel biomarkers for early detection or prognosis.
  • Investigating the functional consequences of PTEN loss in genomic instability could lead to new avenues for cancer treatment.

Related Concept Videos

Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
Trihybrid Crosses02:27

Trihybrid Crosses

Trihybrid Crosses
Some of Mendel’s crosses examined three pairs of contrasting characteristics. Such a cross is called a trihybrid cross. A trihybrid cross is a combination of three individual monohybrid crosses. For example, plant height (tall vs. short), seed shape (round vs. wrinkled), and seed color (yellow vs. green).
The F1 generation plants of a trihybrid cross are heterozygous for all three traits and produce eight gametes. Upon self-fertilization, these gametes have an equal chance to...
Dihybrid Crosses01:18

Dihybrid Crosses

Overview
Crossing Over01:30

Crossing Over

Crossing over is the exchange of genetic information between homologous chromosomes during prophase I of meiosis I. Genetic recombination gives rise to allelic diversity in the newly formed daughter cells. In humans, crossing over produces genetically distinct haploid egg and sperm cells that undergo fertilization to produce unique offspring. Before cell division starts, the germ cell’s chromosome(s) undergo duplication in the S phase of the cell cycle. As the cells enter prophase I, duplicated...
Crossing Over01:34

Crossing Over

Unlike mitosis, meiosis aims for genetic diversity in its creation of haploid gametes. Dividing germ cells first begin this process in prophase I, where each chromosome—replicated in S phase—is now composed of two sister chromatids (identical copies) joined centrally.
The homologous pairs of sister chromosomes—one from the maternal and one from the paternal genome—then begin to align alongside each other lengthwise, matching corresponding DNA positions in a process called synapsis.
In order to...
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...